Cytotoxicity mediation of cells evidencing surface expression of CD44
Details for Australian Patent Application No. 2005226797 (hide)
International Classifications
Event Publications
19 October 2006 PCT application entered the National Phase
PCT publication WO2005/092375 Priority application(s): WO2005/092375
21 May 2009 Assignment before Grant
Arius Research, Inc. The application has been assigned to F.Hoffmann-La Roche AG
18 August 2011 Application Accepted
Published as AU-B-2005226797
15 December 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005226798-Cytotoxicity mediation of cells evidencing surface expression of MCSP
2005226795-Spinal and upper cervical impulse treatment device
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser